Pharma Hikma Reaches $150M Opioid Settlement With States
By Gianna Ferrarin · February 1, 2024, 8:55 PM EST
Hikma Pharmaceuticals and several attorneys general announced a $150 million agreement in principle on Thursday resolving cases brought by a group of states and localities alleging the company fueled the opioid...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login